Xencor to Present at Upcoming Investor Conferences

Rhea-AI Summary

Xencor, a clinical-stage biopharmaceutical company listed on NASDAQ under the symbol XNCR, announced participation in two upcoming investor conferences. The first is the Jefferies London Healthcare Conference on November 15, 2022, at 8:00 a.m. GMT, followed by the Piper Sandler 34th Annual Healthcare Conference on November 29, 2022, at 12:30 p.m. EST. Live webcasts will be accessible via the company’s website, with replays available for 30 days post-event. Xencor specializes in engineered antibodies and cytokines for cancer and autoimmune disease treatments.

MONROVIA, Calif.--(BUSINESS WIRE)-- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will participate at two upcoming investor conferences:

• Jefferies London Healthcare Conference
  Date: Tuesday, November 15, 2022
  Presentation Time: 8:00 a.m. GMT / 12:00 a.m. PST
  Location: London
  

• Piper Sandler 34th Annual Healthcare Conference
  Date: Tuesday, November 29, 2022
  Presentation Time: 12:30 p.m. EST / 9:30 a.m. PST
  Location: New York

Live webcasts of these presentations will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. Replays of the events will be available on the Xencor website for at least 30 days following the presentations.

About Xencor

Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases. More than 20 candidates engineered with Xencor's XmAb^® technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein's structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005834/en/

Charles Liles

cliles@xencor.com

626-737-8118

Source: Xencor, Inc.

FAQ

What is the date of Xencor's participation in the Jefferies London Healthcare Conference?

Xencor will participate in the Jefferies London Healthcare Conference on November 15, 2022.

What time will Xencor present at the Piper Sandler 34th Annual Healthcare Conference?

Xencor's presentation at the Piper Sandler 34th Annual Healthcare Conference is scheduled for 12:30 p.m. EST on November 29, 2022.

Where can I watch the live webcasts of Xencor's investor presentations?

Live webcasts of Xencor's presentations will be available under the 'Events & Presentations' section on their website.

How long will replays of Xencor's presentations be available?

Replays of Xencor's presentations will be available for at least 30 days following the events.

What type of technology does Xencor develop for cancer treatment?

Xencor develops engineered antibodies and cytokines using their XmAb technology for cancer and autoimmune diseases.